Literature DB >> 9916141

The pulmonary circulation of homozygous or heterozygous eNOS-null mice is hyperresponsive to mild hypoxia.

K A Fagan1, B W Fouty, R C Tyler, K G Morris, L K Hepler, K Sato, T D LeCras, S H Abman, H D Weinberger, P L Huang, I F McMurtry, D M Rodman.   

Abstract

Acute hypoxic vasoconstriction and development of hypoxic pulmonary hypertension (PHTN) are unique properties of the pulmonary circulation. The pulmonary endothelium produces vasoactive factors, including nitric oxide (NO), that modify these phenomena. We tested the hypothesis that NO produced by endothelial nitric oxide synthase (eNOS) modulates pulmonary vascular responses to hypoxia using mice with targeted disruption of the eNOS gene (eNOS-/-). Marked PHTN was found in eNOS-/- mice raised in mild hypoxia when compared with either controls or eNOS-/- mice raised in conditions simulating sea level. We found an approximate twofold increase in partially and fully muscularized distal pulmonary arteries in eNOS-/- mice compared with controls. Consistent with vasoconstriction being the primary mechanism of PHTN, however, acute inhalation of 25 ppm NO resulted in normalization of RV pressure in eNOS-/- mice. In addition to studies of eNOS-/- mice, the dose-effect of eNOS was tested using heterozygous eNOS+/- mice. Although the lungs of eNOS+/- mice had 50% of normal eNOS protein, the response to hypoxia was indistinguishable from that of eNOS-/- mice. We conclude that eNOS-derived NO is an important modulator of the pulmonary vascular response to chronic hypoxia and that more than 50% of eNOS expression is required to maintain normal pulmonary vascular tone.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9916141      PMCID: PMC407877          DOI: 10.1172/JCI3862

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  35 in total

1.  Endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension.

Authors:  C Xue; R A Johns
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

2.  Endogenous nitric oxide as a probable modulator of pulmonary circulation and hypoxic pressor response in vivo.

Authors:  M G Persson; L E Gustafsson; N P Wiklund; S Moncada; P Hedqvist
Journal:  Acta Physiol Scand       Date:  1990-12

3.  Augmentation of hypoxic pulmonary vasoconstriction in the isolated perfused rat lung by in vitro antagonists of endothelium-dependent relaxation.

Authors:  V L Brashers; M J Peach; C E Rose
Journal:  J Clin Invest       Date:  1988-11       Impact factor: 14.808

4.  Hypertension in mice lacking the gene for endothelial nitric oxide synthase.

Authors:  P L Huang; Z Huang; H Mashimo; K D Bloch; M A Moskowitz; J A Bevan; M C Fishman
Journal:  Nature       Date:  1995-09-21       Impact factor: 49.962

5.  Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension.

Authors:  A Giaid; D Saleh
Journal:  N Engl J Med       Date:  1995-07-27       Impact factor: 91.245

6.  Chronic EDRF inhibition and hypoxia: effects on pulmonary circulation and systemic blood pressure.

Authors:  V Hampl; S L Archer; D P Nelson; E K Weir
Journal:  J Appl Physiol (1985)       Date:  1993-10

7.  Effect of inhibitors of nitric oxide release and action on vascular tone in isolated lungs of pig, sheep, dog and man.

Authors:  G Cremona; A M Wood; L W Hall; E A Bower; T Higenbottam
Journal:  J Physiol       Date:  1994-11-15       Impact factor: 5.182

8.  Impairment of hypoxic pulmonary artery remodeling by heparin in mice.

Authors:  C A Hales; R L Kradin; R D Brandstetter; Y J Zhu
Journal:  Am Rev Respir Dis       Date:  1983-10

9.  Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans.

Authors:  J S Stamler; E Loh; M A Roddy; K E Currie; M A Creager
Journal:  Circulation       Date:  1994-05       Impact factor: 29.690

10.  Increased endothelium-derived NO in hypertensive pulmonary circulation of chronically hypoxic rats.

Authors:  T C Isaacson; V Hampl; E K Weir; D P Nelson; S L Archer
Journal:  J Appl Physiol (1985)       Date:  1994-02
View more
  79 in total

1.  Hypoxia-induced pulmonary vascular remodeling: a model for what human disease?

Authors:  N F Voelkel; R M Tuder
Journal:  J Clin Invest       Date:  2000-09       Impact factor: 14.808

Review 2.  PPARgamma as a potential therapeutic target in pulmonary hypertension.

Authors:  Roy L Sutliff; Bum-Yong Kang; C Michael Hart
Journal:  Ther Adv Respir Dis       Date:  2010-06       Impact factor: 4.031

3.  Adenoviral gene transfer of endothelial nitric-oxide synthase (eNOS) partially restores normal pulmonary arterial pressure in eNOS-deficient mice.

Authors:  Hunter C Champion; Trinity J Bivalacqua; Stanley S Greenberg; Thomas D Giles; Albert L Hyman; Philip J Kadowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-17       Impact factor: 11.205

4.  Neprilysin null mice develop exaggerated pulmonary vascular remodeling in response to chronic hypoxia.

Authors:  Edward C Dempsey; Marilee J Wick; Vijaya Karoor; Erica J Barr; Dustin W Tallman; Carol A Wehling; Sandra J Walchak; Sven Laudi; Mysan Le; Masahiko Oka; Susan Majka; Carlyne D Cool; Karen A Fagan; Dwight J Klemm; Louis B Hersh; Norma P Gerard; Craig Gerard; York E Miller
Journal:  Am J Pathol       Date:  2009-03       Impact factor: 4.307

5.  Marrow cell infusion attenuates vascular remodeling in a murine model of monocrotaline-induced pulmonary hypertension.

Authors:  Jason M Aliotta; Patrick J Keaney; Rod R Warburton; Michael DelTatto; Mark S Dooner; Michael A Passero; Peter J Quesenberry; James R Klinger
Journal:  Stem Cells Dev       Date:  2009-06       Impact factor: 3.272

6.  Mechanisms underlying selective coupling of endothelial Ca2+ signals with eNOS vs. IK/SK channels in systemic and pulmonary arteries.

Authors:  Matteo Ottolini; Zdravka Daneva; Yen-Lin Chen; Eric L Cope; Ramesh B Kasetti; Gulab S Zode; Swapnil K Sonkusare
Journal:  J Physiol       Date:  2020-06-11       Impact factor: 5.182

7.  Antenatal maternally-administered phosphodiesterase type 5 inhibitors normalize eNOS expression in the fetal lamb model of congenital diaphragmatic hernia.

Authors:  Eveline H Shue; Samuel C Schecter; Wenhui Gong; Mozziyar Etemadi; Michael Johengen; Corey Iqbal; S Christopher Derderian; Peter Oishi; Jeffrey R Fineman; Doug Miniati
Journal:  J Pediatr Surg       Date:  2013-10-05       Impact factor: 2.545

8.  Changes in functional and histological distributions of nitric oxide synthase caused by chronic hypoxia in rat small pulmonary arteries.

Authors:  Mikiyasu Shirai; James T Pearson; Akito Shimouchi; Noritoshi Nagaya; Hirotsugu Tsuchimochi; Ishio Ninomiya; Hidezo Mori
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

9.  Deficiency of actinin-associated LIM protein alters regional right ventricular function and hypertrophic remodeling.

Authors:  Ilka Lorenzen-Schmidt; Andrew D McCulloch; Jeffrey H Omens
Journal:  Ann Biomed Eng       Date:  2005-07       Impact factor: 3.934

10.  Endothelial GATA-6 deficiency promotes pulmonary arterial hypertension.

Authors:  Angela Ghatnekar; Izabela Chrobak; Charlie Reese; Lukasz Stawski; Francesca Seta; Elaine Wirrig; Jesus Paez-Cortez; Margaret Markiewicz; Yoshihide Asano; Russell Harley; Richard Silver; Carol Feghali-Bostwick; Maria Trojanowska
Journal:  Am J Pathol       Date:  2013-04-11       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.